# Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients

> **NCT00441974** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1470 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** adefovir dipivoxil

## Key facts

- **NCT ID:** NCT00441974
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 1470 (ACTUAL)
- **Last updated:** 2009-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00441974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00441974, "Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients". Retrieved via AI Analytics 2026-09-12 from https://api.ai-analytics.org/clinical/NCT00441974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*